These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2005-001574-27||Sevoflurane on cardiac surgery: vantage to use during CEC||not-yet-due|
|Ongoing||2006-006210-14||PIPERACILLIN/TAZOBACTAM PLUS TIGECYCLINE VS. PIPERACILLIN/TAZOBACTAM ALONE AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC CANCER PATIENTS : A PROSPECTIVE, RANDOMISED, MULTI-CENTRE, STUDY.||not-yet-due|
|Completed, but no date||2007-006773-92||Sodium Valproate in the treatment of medication overuse headache: a controlled randomized clinical trial.||bad-data|
|Ongoing||2008-002077-12||Fenoldopam end Renal failure (FENO-HSR)||not-yet-due|
|Ongoing||2008-008382-35||Open , multicenter, randomized trial comparing two therapeutic approaches for the treatment of invasive fungal infections in neutropenic onco-hematologic patients.Empiric vs. ``presumptive`` (preempt...||not-yet-due|
|Ongoing||2009-017437-22||MANAGEMENT OF PRIMARY AND SECUNDARY PERITONEAL CARCINOMATOSIS FROM COLO-RECTAL CANCER, RECURRENT OVARIAN CANCER AND ABDOMINAL SARCOMATOSIS BY CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CH...||not-yet-due|
|Ongoing||2009-017603-28||Aprepitant for prevention of acute and delayed nausea and vomiting: a phase III, double-blind, randomized, palcebo-controlled trial in patients receiving a high-emetogenic dose of cyclophosphamide for...||not-yet-due|
|Ongoing||2011-002992-40||PREvention of VENous Thromboembolism In Hemorrhagic Stroke patients||not-yet-due|
|Ongoing||2011-005487-13||A phase II, multi-center, open label study of the clinical activity and safety of the BRAF-V600 inhibitor vemurafenib (PLX-4032) in previously treated patients with hairy cell leukemia (HCL) carrying...||not-yet-due|
|Ongoing||2014-000693-18||A PHASE II STUDY OF THE CLINICAL ACTIVITY AND SAFETY OF ACTINOMYCIN D IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA WITH NUCLEOPHOSMIN (NPM1) GENE MUTATION||not-yet-due|
|Ongoing||2020-001475-33||Treatment with COLchicine of patients affected by COVID-19: a Pilot Study||not-yet-due|